Precision cancer medicine is an evolving approach to cancer care that personalizes treatment based on each patient’s unique genetic mutations.
Since 2011, Dana-Farber has used its Profile research project, in partnership with Brigham and Women’s Hospital and Boston Children’s Hospital, to gather adult and pediatric patients’ tumor tissues and detect genetic alterations that may hold the key to successfully treating patients’ diseases.
Like each person is different, every tumor is different – even within the same subsets of cancer. Through precision cancer medicine, clinicians and researchers tailor treatment to the genetic makeup of each patient’s cancer cells.
Review the infographic below to learn more about precision cancer medicine and the Profile research project.